How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)

BACKGROUND: The randomised, double-blind, placebo-controlled Systolic Hypertension in Europe trial (Syst-Eur 1) proved that blood pressure (BP) lowering therapy starting with nitrendipine reduces the risk of cardiovascular complications in elderly patients with isolated systolic hypertension. In an...

Descripción completa

Detalles Bibliográficos
Autores principales: Thijs, Lutgarde, Staessen, Jan A, Beleva, Sonia, Birkenhäger, Willem H, Bulpitt, Christopher J, Celis, Hilde, Fletcher, Astrid E, Kermova, Rumjana, Leonetti, Gastone, Laks, Tovio, Mantov, Stefan, Nachev, Choudomir, Sarti, Cinzia, Tuomilehto, Jaakko, Fagard, Robert H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64833/
https://www.ncbi.nlm.nih.gov/pubmed/11806817
http://dx.doi.org/10.1186/cvm-2-6-298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64833/
https://www.ncbi.nlm.nih.gov/pubmed/11806817
http://dx.doi.org/10.1186/cvm-2-6-298

Ejemplares similares